Visla Labs develops an AI-driven medical diagnostics platform focused on radiology. Its core product applies machine learning to support radiological diagnosis and is in early previews covering people in more than 30 clinical settings across the US and Asia. The company will use new capital to grow its team, scale product features, attain regulatory approval, and accelerate expansion and growth. Visla is actively pursuing regulatory clearance as part of its commercialization strategy. The company was founded in 2018 by Kevin Quennesson, Wei-En Tan and Alessandro Sabatelli.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2018